Iodomethane

Iodomethane

SCHEMBL8058645

CI.ON=Cc1ccncc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.47
CTH P32929 1/20 0.44
GAA P10253 5/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
KMT2A Q03164 3/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
MEN1 O00255 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
JUN P05412 1/20 0.39
NFKB1 P19838 1/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL982231 0.93
SCHEMBL352177 0.93
SCHEMBL591208 0.93
Hydrochloric Acid SCHEMBL6901823 0.91 ACHE (0.45) ACHECTHGAAKDM4EALDH1A1
Bromide SCHEMBL28108732 0.91 ACHE (0.45) ACHECTHGAAKDM4EALDH1A1
Bromide SCHEMBL7180391 0.91 ACHE (0.45) ACHECTHGAAKDM4EALDH1A1
SCHEMBL29720380 0.84 KMT2A (0.44) ACHECTHGAAKMT2ANPC1
SCHEMBL9712709 0.84 KMT2A (0.44) ACHECTHGAAKMT2ANPC1
Isonicotinonitrile SCHEMBL27701693 0.78 GRK2 (0.48) ACHECTHGAAKDM4EALDH1A1
SCHEMBL5668373 0.74 KMT2A (0.64) ACHEGAAKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166032-A Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 2000-12-26 US claimed
US-6166032-A Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 2000-12-26 US disclosed
EP-1014981-A1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SYNAPTIC DYSFUNCTION COMPRISING AN OXIME Synapse Pharmaceuticals International, Inc. (CA) 2000-07-05 EP disclosed
US-5981549-A Method for controlling or alleviating the symptoms of respiratory disease and allergies SYNAPSE PHARMACEUTICAL INTERNATIONAL (CA) 1999-11-09 US disclosed
US-5916903-A Method for reducing the effects of antineoplastic disease treatment SYNAPSE PAHRMACEUTICALS INTERNATIONAL, INC. (CA) 1999-06-29 US disclosed
US-5902816-A Method for treatment of heavy metal poisoning SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 1999-05-11 US disclosed
US-5900418-A Method for treatment of obesity SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 1999-05-04 US disclosed
US-5824684-A Method for treating drug and alcohol addiction SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 1998-10-20 US disclosed
WO-1998034615-A1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SYNAPTIC DYSFUNCTION COMPRISING AN OXIME SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 1998-08-13 WO disclosed
US-5760049-A Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 1998-06-02 US disclosed